NanoViricides Inc

NanoViricides Inc a nanobiopharmaceutical research and development company discovers develops and commercializes drugs for the treatment of viral infections The company develops Human Coronavirus Program for COVID19 seasonal coronavirus affliction HerpeCide Dermal Topical and Eye Drops for the treatment of shingles PHN chickenpox herpes recurrent herpes labialis genital herpes and ocular herpes keratitis and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide BroadSpectrum AntiInfluenza nanoviricide which is injectable for hospitalized patients and oral for outpatients Nanoviricide eye drops for viral diseases of the external eye DengueCide for treatment of various types of Dengue viruses and HIVCide an escaperesistant antiHIV nanoviricide In addition it develops other nanoviricides drug projects for treatment of different viruses and indications and HerpeCide program expansion drug projects for different herpes viruses for different indications NanoViricides Inc was founded in 2005 and is based in Shelton Connecticut